Furthermore, the inhibitory function of si-HCP5 against OC metastasis and growth was verified in a xenograft model established with OC cells, the results of which were in line with the research of HCP5 in nasopharyngeal carcinoma (Miao et al. 2022) and in triple-negative breast cancer (Wang et al. 2019). The gene discussed is HCP5; the disease is triple-negative breast carcinoma.